Skinvisible, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Skinvisible, Inc. (SKVI) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $8.60 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2026-03-31
- 2025-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $8.60M.
- 2024-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $8.40M.
- 2023-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $8.30M.
- 2022-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $7.80M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2025-12-31 | $8.60M 10-K · filed 2026-03-31 |
| 2024-12-31 | $8.40M 10-K · filed 2026-03-31 |
| 2023-12-31 | $8.30M 10-K · filed 2025-04-14 |
| 2022-12-31 | $7.80M 10-K · filed 2024-04-16 |
| 2021-12-31 | $3.30M 10-K · filed 2023-03-30 |
| 2020-12-31 | $3.00M 10-K · filed 2022-03-31 |
| 2019-12-31 | $2.80M 10-K · filed 2021-04-15 |
| 2018-12-31 | $2.70M 10-K · filed 2020-05-14 |